Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec

Vikram M. Narayan(Emory University), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Seppo Ylä‐Herttuala(University of Eastern Finland), Vincent T. Bicocca(Convergent Science (United States)), Vincent M. Caruso(Convergent Science (United States)), Sharada Mokkapati(The University of Texas MD Anderson Cancer Center), Alberto Martini(The University of Texas MD Anderson Cancer Center), Mahdi Goudarzi(Convergent Science (United States)), Côme Tholomier(The University of Texas MD Anderson Cancer Center), Trevor G. Levin(Convergent Science (United States)), David J. McConkey(Johns Hopkins University), Brian C. Mazzarella(Universidad de América), Kevin G. Phillips(Convergent Science (United States))
European Urology Oncology
October 15, 2024
Cited by 18


Related Papers